CG Oncology, Inc. Common stock
(CGON - NASDAQ)
66,68 USD
📋 Profilo Aziendale

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.

|